Kezar Life Sciences, Inc. (KZR)

7.29 0.00 (0.00%) USD  |  NASDAQ  |  Aug 28, 16:00
More

Kezar Life Sciences Revenue Estimates for Next Fiscal Year

Revenue Estimates for Next Fiscal Year Chart

View Revenue Estimates for Next Fiscal Year for KZR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Next Fiscal Year Chart
Start Trial

Historical Revenue Estimates for Next Fiscal Year Data

View and export this data back to 2023. Start Trial.
Date Value
May 11, 2026 --
April 22, 2026 --
March 30, 2026 --
February 20, 2026 --
November 13, 2025 --
October 17, 2025 --
October 16, 2025 --
September 24, 2025 --
August 14, 2025 --
July 16, 2025 --
May 14, 2025 --
May 13, 2025 --
March 25, 2025 --
February 28, 2025 --
February 21, 2025 --
December 19, 2024 --
December 02, 2024 --
Date Value
November 14, 2024 --
November 13, 2024 --
August 15, 2024 --
August 14, 2024 --
August 13, 2024 --
April 04, 2024 --
March 15, 2024 --
February 23, 2024 --
November 27, 2023 --
November 14, 2023 --
October 04, 2023 --
September 25, 2023 --
September 21, 2023 --
August 11, 2023 --
May 12, 2023 --
May 11, 2023 --
March 16, 2023 --

Revenue Estimates for Next Fiscal Year Range, Past 5 Years

View Revenue Estimates for Next Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Fiscal Year Benchmarks

View Revenue Estimates for Next Fiscal Year Benchmarks
Start Trial
NovelStem International Corp. Upgrade
Brainstorm Cell Therapeutics, Inc. Upgrade
Summit Therapeutics, Inc. Upgrade
Protara Therapeutics, Inc. Upgrade
Clene, Inc. Upgrade

Revenue Estimates for Next Fiscal Year Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade